Table 9.
Treatment | Ala | Asp | Cys | Glu | Gly | Pro | Ser | Tyr2 |
---|---|---|---|---|---|---|---|---|
C | 82b,c | 82b | 78a,b | 90c | 81a,b | 88b | 83b,c | 85c |
C+MI | 81c | 81c | 77b | 89d | 80b | 87c | 82c | 84d |
Phy500 | 83a,b | 83b | 78a | 91b,c | 81a | 88a,b | 84a,b | 86b,c |
Phy1500 | 84a | 84a | 79a | 92a | 82a | 89a,b | 85a | 87a |
Phy3000 | 84a | 84a | 79a | 91a,b | 82a | 89a | 85a | 86a,b |
Pooled SEM | 0.46 | 0.47 | 0.54 | 0.30 | 0.47 | 0.35 | 0.46 | 0.41 |
P-value | 0.001 | <0.001 | 0.004 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
1Data are given as treatment means; n = 8 pens.
2The concentrations of tyrosine may be affected to some extent by the oxidation procedure (Mason et al., 1980).
a–dMeans within a column not showing a common superscript differ (P < 0.05).